Skip to content

Medical-device intelligence

PGH: Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel

FDA product code PGH: Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PGH
FDA device name
Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel
Device class
2
Regulation number
866.3307
Medical specialty
Microbiology
Review panel
MI

FDA definition

Intended for the qualitative detection and differentiation of HSV-1 and HSV-2 in cerebrospinal fluid (CSF) from patients with signs and symptoms of Herpes Simplex Virus (HSV) central nervous system (CNS) infection. This test is an aid in the diagnosis of HSV-1 and HSV-2 CNS infections in conjunction with other clinical and laboratory findings. Negative results do not preclude HSV-1 or HSV-2 infection and should not be used as the sole basis for treatment or other patient management decisions.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 1 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Jul 1, 2014 to Sep 30, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
PGH · Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel21

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
miDiagnostics HSV-1&2 CSF TestK250050 · PGHMidiagnostics NV510(k)Sep 30, 2025FDA decision date
Simplexa HSV 1&2 Direct (MOL2150) with Direct Amplification Disc (MOL1451, MOL1452, MOL1455) Model Number: MOL2150, MOL1451, MOL1452, MOL1455Z-1272-2016 · PGHFocus Diagnostics IncRecallApr 2, 2016FDA classification date
SIMPLEXA HSV 1&2 DIRECT/POSITIVE CONTROL PACKK141458 · PGHFocus Diagnostics510(k)Jul 1, 2014FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗